PR Newswire - Live from EHA 2024 | Ascentage Pharma Releases Upd...
SUZHOU, China and ROCKVILLE, Md., June 18, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CH...
Read More

ภาษาไทย
English